Are you a new member? Sign up now
Login area
| Sign up
close
ZALTRAP - 200mg/8ml - 1
| ATC | B/G | Ingredients | code | Registration Nb | brand_name | Dosage | Presentation | Form | Route | Agent | Laboratory | man_country | Price | Pharmacist Margin | Startum | Responsible Party Name | Responsible Party Country | Exch_date | %SUBSIDY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| L01XX44 | BioTech | Aflibercept - 200mg/8ml | 11807 | 109223/1 | ZALTRAP | 200mg/8ml | 1 | Injectable concentrate for solution | Infusion | Mersaco | Sanofi Aventis Deutschland GmbH | Germany | 63,807,499 L.L | 10.71 | E1 | Sanofi Winthrop Industrie | France | 2/5/2024 | 0 |
Drug Substitutes
| ATC | B/G | Ingredients | code | Registration Nb | brand_name | Dosage | Presentation | Form | Route | Agent | Laboratory | man_country | Price | Pharmacist Margin | Startum | Responsible Party Name | Responsible Party Country | Exch_date | %SUBSIDY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| L01XX44 | BioTech | Aflibercept - 200mg/8ml | 7638 | 186626/13 | ZALTRAP | 200mg/8ml | 1 | Injectable concentrate for solution | Infusion | Mersaco | Sanofi Aventis Deutschland GmbH | Germany | 63,807,499 L.L | 10.71 | E1 | Sanofi Aventis Groupe | France | 2/5/2024 | 0 |
Sitemap
© Copyrights reserved to Ministry of Public Health 2024